-
1 Comment
Yifeng Pharmacy Chain Co., Ltd is currently in a long term downtrend where the price is trading 27.4% below its 200 day moving average.
From a valuation standpoint, the stock is 59.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
Yifeng Pharmacy Chain Co., Ltd's total revenue rose by 34.3% to $3B since the same quarter in the previous year.
Its net income has increased by 61.6% to $178M since the same quarter in the previous year.
Finally, its free cash flow grew by 1094.8% to $362M since the same quarter in the previous year.
Based on the above factors, Yifeng Pharmacy Chain Co., Ltd gets an overall score of 4/5.
Exchange | SHG |
---|---|
CurrencyCode | CNY |
ISIN | CNE100001TS5 |
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
Beta | 0.59 |
---|---|
Market Cap | 34B |
PE Ratio | 21.85 |
Target Price | 36.56 |
Dividend Yield | None |
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. The company is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals. It also offers its products through franchise distribution and e-commerce. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603939.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025